Advertisement
Sunday, Jan 23, 2022
Outlook.com
Outlook.com

NTAGI To Soon Unleash Roadmap For Zydus Cadila's Covid-19 Vaccination Drive

'The aim is to develop a priority list with the focus being on adolescents aged 12-18 years with comorbidities,' Dr N K Arora said.

NTAGI To Soon Unleash Roadmap For  Zydus Cadila's Covid-19 Vaccination Drive
Representational Image | File Photo
NTAGI To Soon Unleash Roadmap For Zydus Cadila's Covid-19 Vaccination Drive
outlookindia.com
2021-08-25T16:24:10+05:30

In a bid to chalk out an appropriate roadmap to be followed for Zydus Cadila's Covid-19 vaccination drive, the National Technical Advisory Group on Immunisation (NTAGI) will soon hold a meeting and will prioritise beneficiaries focusing on those aged between 12-18 years with comorbidities.

The drug regulator Drug Controller General of India (DCGI) recently granted the indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D Emergency Use Authorisation (EUA) on August 20 making it the first vaccine to be administered in the age group of 12-18 years in the country.

NTAGI Chairman Dr N K Arora said it is estimated that there are around 12 crore adolescents in the age group of 12-18 years in India and less than 1 per cent of them may have comorbidities.

"The NTAGI's meeting will be held soon to chalk out a roadmap for introducing the three-dose ZyCoV-D vaccine in the ongoing COVID-19 vaccination drive. The meeting will also focus on prioritisation of beneficiaries as this vaccine is approved for both adolescents and adults," he said.

"The aim is to develop a priority list with the focus being on adolescents aged 12-18 years with comorbidities," Dr Arora said.

The NTAGI will provide the protocol and framework for the introduction of this vaccine in the COVID-19 immunisation drive.

Covishield, Covaxin and Sputnik V vaccines are being given to only those above 18 years and unlike ZyCoV-D, which is three-dose, these are administered in two doses.

The Department of Biotechnology (DBT) has said that ZyCoV-D is the world's first DNA-based vaccine against the coronavirus and when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance.

It said that interim results from Phase-III clinical trials in over 28,000 volunteers showed primary efficacy of 66.6 per cent for symptomatic RT-PCR positive cases. This has been the largest vaccine trial so far in India for COVID-19, the DBT said.

The vaccine had already exhibited robust immunogenicity and tolerability and safety profile in the adaptive Phase one and two clinical trials. Both Phase one/two and Phase three clinical trials have been monitored by an independent data safety monitoring board, it added. 

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement